Episode 64 · March 12, 2026 · 38m listen · 7,315 words · ~37 min read

How to Design Devices That Integrate Into Clinical Workflow Without Disruption | Ep. 61 - Full Transcript | The Med Device Cyber Podcast

Read the complete, searchable transcript of Episode 64 of The Med Device Cyber Podcast - expert conversations on medical device cybersecurity, FDA premarket and postmarket guidance, SBOM management, threat modeling, and penetration testing.

Prefer the listening experience? Open the episode page for the synopsis, key takeaways, topics, and Apple / YouTube listen links.

Episode summary

In this episode of the Med Device Cyber podcast, hosts Christian Espinosa and Trevor Slattery are joined by Professor Aamer Ahmed, a practicing cardiac anesthesiologist and co-founder of the MedTech company Hemeo. The discussion centers on the critical role of clinical expertise in medical device innovation and the paramount importance of cybersecurity in healthcare technology. Professor Ahmed is introduced as a Key Opinion Leader (KOL), a term he defines as a recognized expert in a specific medical field who contributes to academic research, publishes guidelines, and helps shape the best practices that are followed globally. He explains that industry often consults KOLs to gain an accurate understanding of the clinical landscape and ensure that new technologies are addressing real-world problems. A central argument made by Professor Ahmed is that a frequent failure in the MedTech industry is the development of a "solution in search of a problem." Many companies create technologically impressive devices without first immersing themselves in the clinical environment to understand the actual needs and workflows of physicians. He stresses that for a product to be successful and widely adopted, it must solve a genuine problem and integrate seamlessly into the high-pressure, fast-paced setting of a hospital or clinic. If a device disrupts or complicates a doctor's established process, it is unlikely to be used, regardless of its innovations. This leads to his core advice for MedTech innovators: start by identifying a problem with the help of clinicians, rather than starting with a technology and trying to force its application. The conversation also delves into the significant cybersecurity implications of these technologies. Dr. Ahmed emphasizes that the integrity and reliability of data from medical devices are absolutely vital. As an end-user, he needs to have complete trust that the information he receives—whether from a monitor in the operating room or a remote device—has not been tampered with, as this data directly informs life-or-death treatment decisions. The hosts explore this further, discussing the blurry line between unregulated wellness devices (like sleep-tracking rings) and official medical devices. They note that wellness products carefully avoid making direct medical claims to stay outside of stringent regulatory frameworks, which limits their utility. The episode concludes by looking toward the future, including the concept of the 'digital twin' for personalized medicine and the complex questions of liability that will arise as AI begins to provide not just data, but direct therapeutic recommendations.

Key takeaways from this episode

Cybersecurity in MedTech is vital for patient safety because clinicians must have absolute trust in the integrity of the data used for making treatment decisions.
A common pitfall for MedTech innovators is creating a "solution in search of a problem." To be successful, companies should start by working with clinicians to identify and understand a genuine clinical need.
New medical devices must integrate seamlessly into existing clinical workflows and IT systems; if a device hinders a physician's process, it will likely fail to gain adoption.
Key Opinion Leaders (KOLs) are medical experts who play a crucial role in vetting new technologies and guiding MedTech companies to create products that are clinically relevant and effective.
There is a fine, but significant, regulatory line between general wellness products and medical devices, which hinges on whether a device makes specific, actionable medical claims or provides direct advice.
The future of medicine is moving towards personalized treatment and predictive analytics, using technologies like "digital twins" to model individual patient physiology.
As AI becomes more involved in making therapeutic recommendations, the accuracy of the underlying data becomes paramount, and complex legal questions about liability (manufacturer vs. physician) will need to be addressed.
Alarm fatigue is a real phenomenon where clinicians become desensitized to frequent, often false, alarms from monitoring equipment, underscoring the need for reliable and accurate device data.

Full episode transcript

Host: Cybersecurity in MedTech is absolutely vital because the key thing is that the doctors who are the end users have to be dead sure that what we're receiving is not been hacked, the data is reliable and then we can use that to actually treat our patients. And that is something that many, many, many MedTech companies get wrong because they come up with a solution and they start looking for a problem to solve. And the biggest issue I think we find with MedTech is the integration into the IT systems of hospitals. Guest: And especially for one of these wellness tools where it can't make any claims to anything. And so reading through it, it never says, you know, "Oh, you need to get more sleep, you need to go to bed earlier tonight." It just says, "You didn't sleep well last night." Okay, cool. So what's the response? What do you do as the next step? And it's a hard problem to solve for these wellness companies because then you're bridging the line between a wellness product and a medical device where obviously becoming a medical device is a big deal. Christian: Hi, welcome back to another episode of the Med Device Cyber podcast. Today we're talking about an a very important topic and a topic that is misunderstood. I didn't know much about it until maybe a year and a half ago. It's about KOLs or Trevor, what does a KOL stand for? Do you remember? Trevor: A key opinion leader. Christian: Yes, so we have a KOL on the call today. Uh, Dr. Aamer Ahmed and maybe you can explain a little bit about what uh you do and what's your role is with uh Hemeo and also as a KOL. Aamer: Great, thank you. I'd like to thank you both for inviting me to speak here. It's it's an honor and absolute pleasure. Um, so my background is a, I'm a professor of cardiac anesthesiology and critical care in the University of Leicester in the UK. And what that means is I'm a practicing, full-time cardiac anesthesiologist, but also I am a uh co-founder of the company Hemeo, uh for which we're going to talk about a little bit later on. Now, just uh to go into the key opinion leader business, the reason why we're called that is because we, um, a handful of us, if you like, across the world, are known as leaders in our field, and we publish a lot of the academic papers, a lot of clinical research, and a lot of the international guidelines that define what the best practice or current state of the art in medicine is. And each one of us works in a different field. I work in the area of cardiac anesthesia and critical care, but others work in, you know, oncology, hematology, and others. And so what we do is we publish the guidelines on the basis of best practice and evidence. So we look at all of the papers out there, we look at all of the evidence and we make decisions as a group, not just individuals, but as a group of us and publish these as guidelines that other hospitals take as best practice. So when you go into a hospital as a patient, you know that you're going to get treated with the best available evidence by your physician. And that's what defines us as a key opinion leader because industry like to call us that because we're the ones who effectively formulate opinions within all our other peer group. And so what we tend to say is evidence based and what we tend to publish tends to get followed by the majority of clinicians across the world. And that's what a KOL is. So it's a label attached to me and many of my colleagues. Um, but essentially once you're a real expert in the field and you are recognized as somebody who really knows what they're doing and they publish in that subject, that's how they become key opinion leaders. And that takes many, many years. I've been a cardiac anesthesiologist for over a quarter of a century. So I've been practicing this and doing this and honing my craft if you like and become an expert in the field over many, many years. And that's how we get known in the field. That's why we get invited to speak at scientific conferences and then we end up in podcast rooms like this with yourselves. Christian: Well, awesome. I th- I think it's uh important like from my perspective and I I could have the wrong perspective, I'm not an expert on KOLs. I I maybe I am a KOL in my field, I guess. But from my perspective, you've got a lot of medical device innovators that don't have a KOL on as part of their team so there's a pretty high opportunity for, the product to not actually fit a need or not work in a clinical setting. Is that a fair assessment? Because I know what you do with Hemeo is you provide the the real knowledge of how this how your device and products would work in the environment.

1 / 9